Acetazolamide for Treatment Resistant Schizophrenia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vishwajit L Nimgaonkar, M.D., Ph.D.
University of Pittsburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St John'S Medical College Hospital
Bangalore, India
Anil Kakunje, M.D.Ashok Mysore, M.D.Smita Deshpande, M.D.Recruiting
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Ian Conner, M.D.Konasale Prasad, M.D.Madhavi K Ganapathiraju, Ph.D.Maribeth A Wesesky, BPSRoy KN Chengappa, M.D.Satish Iyengar, Ph.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Feb 2022
- Primary completion
- 30 Dec 2027
- Completion
- 30 Jun 2028
- Last update posted
- 7 Jul 2026
- Registered enrollment
- 60
- Registry id
- NCT04887792
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.